ANGLE plc (LSE:AGL) — Market Cap & Net Worth
Market Cap & Net Worth: ANGLE plc (AGL)
ANGLE plc (LSE:AGL) has a market capitalization of $94.18K (GBX774.07 Million) as of September 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31515 globally and #1131 in its home market, demonstrating a 29.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ANGLE plc's stock price GBX2.40 by its total outstanding shares 322528409 (322.53 Million). Also see AGL asset base for a full breakdown of the balance sheet.
ANGLE plc Market Cap History: 2015 to 2025
ANGLE plc's market capitalization history from 2015 to 2025. Data shows change from $2.81 Million to $94.18K (-29.58% CAGR). Also see AGL cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
ANGLE plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$912.31 Million | 0.01% | #363 of 722 |
Weight: ANGLE plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ANGLE plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ANGLE plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check AGL live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.14x
ANGLE plc's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.91 Million | $361.00K | -$4.89 Million | 5.30x | N/A |
| 2017 | $2.18 Million | $498.00K | -$6.57 Million | 4.37x | N/A |
| 2018 | $1.53 Million | $628.00K | -$7.56 Million | 2.44x | N/A |
| 2019 | $2.46 Million | $871.50K | -$11.33 Million | 2.82x | N/A |
| 2019 | $2.46 Million | $678.00K | -$8.94 Million | 3.63x | N/A |
| 2020 | $1.87 Million | $762.00K | -$11.61 Million | 2.46x | N/A |
| 2021 | $4.67 Million | $1.01 Million | -$15.01 Million | 4.61x | N/A |
| 2022 | $1.98 Million | $1.04 Million | -$21.69 Million | 1.90x | N/A |
| 2023 | $461.10K | $2.19 Million | -$20.13 Million | 0.21x | N/A |
| 2024 | $402.23K | $2.86 Million | -$14.22 Million | 0.14x | N/A |
Competitor Companies of AGL by Market Capitalization
Companies near ANGLE plc in the global market cap rankings as of September 19, 2026. Review ANGLE plc (AGL) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to ANGLE plc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $149.61 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #475 globally with a market cap of $57.91 Billion USD ( CN¥395.72 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $651.45 |
| #161 | Danaher Corporation | NYSE:DHR | $149.61 Billion | $211.81 |
| #475 | WuXi AppTec Co Ltd | SHG:603259 | $57.91 Billion | CN¥160.00 |
| #577 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $369.39 |
ANGLE plc Historical Marketcap From 2015 to 2025
Between 2015 and today, ANGLE plc's market cap moved from $2.81 Million to $ 94.18K, with a yearly change of -29.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | GBX94.18K | -76.59% |
| 2024 | GBX402.23K | -12.77% |
| 2023 | GBX461.10K | -76.73% |
| 2022 | GBX1.98 Million | -57.56% |
| 2021 | GBX4.67 Million | +149.21% |
| 2020 | GBX1.87 Million | -23.84% |
| 2019 | GBX2.46 Million | +60.77% |
| 2018 | GBX1.53 Million | -29.73% |
| 2017 | GBX2.18 Million | +13.85% |
| 2016 | GBX1.91 Million | -31.82% |
| 2015 | GBX2.81 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of ANGLE plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $94.18K USD |
| MoneyControl | $94.18K USD |
| MarketWatch | $94.18K USD |
| marketcap.company | $94.18K USD |
| Reuters | $94.18K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ANGLE plc
ANGLE plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis. It also provides Portrait+ C… Read more